Mark For: A® trademark registration is intended to cover the categories of pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases; cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases. [all]
Status
2022-08-30 UTC
DEAD REGISTRATION Cancelled Invalidated
The trademark application was registered, but subsequently it was cancelled or invalidated and removed from the registry.
3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S)
Mark Type
TRADEMARK
Standard Character Claim
No
Register
PRINCIPAL
Current Location
SCANNING ON DEMAND 2007-04-23
Basis
1(a)
Class Status
SECTION 8 - CANCEL
Primary US Classes
006:
Chemicals and Chemical Compositions
018:
Medicines and Pharmaceutical Preparations
044:
Dental, Medical and Surgical Appliances
046:
Foods and Ingredients of Foods
051:
Cosmetics and Toilet Preparations
052:
Detergents and Soaps
Primary International Class
005 - Primary Class
(Pharmaceuticals) Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
Filed Use
Yes
Current Use
Yes
Intent To Use
No
Filed ITU
No
44D Filed
No
44E Current
No
66A Current
No
Current Basis
No
No Basis
No
Cancellation Code
2
Attorney Name
Beth M. Goldman
Law Office Assigned
M40
Employee Name
VAN HORN, TAWANDA
Timeline
1997-12-29
Date of First Use
1997-12-29
Date of Use In Commerce
2001-05-11
Application Filed
2001-10-09
Published
2001-10-09
Published for Opposition
2002-01-01
Trademark Registered
2007-04-23
Location: SCANNING ON DEMAND
2008-10-04
Cancelled
2008-10-04
Status: Dead/Cancelled
2008-10-04
Status: Registration cancelled because registrant did not file an acceptable declaration under Section 8. To view all documents in this
BETH M. GOLDMAN HELLER EHRMAN WHITE & MCAULIFFE LLP 333 BUSH ST SAN FRANCISCO CA 94104-2806
Good, Services, and Codes
(CANCELLED) IC 005. US 006 018 044 046 051 052. G & S: Pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases; cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases. FIRST USE: 19971229. FIRST USE IN COMMERCE: 19971229
International Codes:
5
U.S. Codes:
006,018,044,046,051,052
Type Code
Type
GS0051
Pharmaceuticals, namely, monoclonal antibodies and fragments thereof for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases; cell lines for clinical, diagnostic and therapeutic use for the treatment of cancer, auto immune diseases, infectious diseases, inflammatory diseases and genetic diseases
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.